# CHARTERHOUSE PHARMACEUTICS — NAFDAC-Registered Products & Company Profile

CHARTERHOUSE PHARMACEUTICS holds 3 active NAFDAC product registrations in our October 2026 copy of the Greenbook.

- Source: https://ogbogwu.com/manufacturers/charterhouse-pharmaceutics/
- NAFDAC-registered products: 3 · Hypertension, Antimalarials
- Made in: India (3)
- Address & phone: Not on record — the NAFDAC Greenbook lists products, not offices.
- Rank by registered products: 443 of 533 manufacturers tracked (October 2026 copy)
- Nigerian company: no

## Register profile (October 2026 copy)

CHARTERHOUSE PHARMACEUTICS has 3 products registered with NAFDAC for the Nigerian market in our October 2026 copy of the Greenbook. The full list below is compiled from that copy of the NAFDAC Greenbook — Nigeria's official register of approved products.
Its medicines are strongest in Hypertension (2 products) and Antimalarials (1 product). Registered brands include Comalart Plus Tablets and Diplovas 10 mg tablets. Most of its products are registered as tablet formulations. 3 of its products link through to full Ogbogwu drug guides covering uses, dosage, prices, and NAFDAC verification. CHARTERHOUSE PHARMACEUTICS is the registration holder rather than the physical maker: the Greenbook records factories abroad for its products (mostly India).

## Product categories (October 2026 copy)

- Hypertension: 2 products
- Antimalarials: 1 product

## Registered products in our October 2026 copy

| Product | NAFDAC Reg. No. | Strength | Form |
|---|---|---|---|
| Comalart Plus Tablets | B4-5253 | 80 mg; 480 mg | Tablet |
| Diplovas 10 mg tablets | B4-5410 | 10 mg | Tablet |
| Diplovas 5 mg Tablets | B4-5370 | 5 mg | Tablet |

Verify any NAFDAC number free: https://ogbogwu.com/nafdac-checker/